A few media stories to update. Three stories across 3 different...

A few media stories to update. Three stories across 3 different regions (and of course lots more other stories out there). I've just taken media that has more of a government/regulatory backing that seems significant enough to highlight. The 'wave' for the demand for rapid antigen tests is quite strong at the moment, and seems to be at that inflection point where Australia/NZ could very well go gun-ho on it in the next 6-12 months before it tapers off and we find the 'new norm' for such testing.

I believe that right now, any commercial agreements will be to 'test the waters', because who really knows what the regulations will be in the future for on-going testing. How often? Do we even need it? Who will be required to undergo the tests? In which scenarios will they be required? I imagine the answers to these questions right now could change in 6-12 months time, but one thing is for sure - in the next 6-12 months.....demand for these antigen tests are high, and supply will be low.

1. Bermuda Health Council publishes a list of tests that have met their standards of very high specificity and very high sensitivity against viral loads, approving those on their list for use. Access Bio's CareStart (both the home test and the professional test) are there, as expected.


2. Additional spending from US government for rapid at-home tests




3. NZ will announce new COVID-19 testing regime today, which is expected to place a higher importance on rapid antigen tests